In real-world data, short-term results favor one but the other is better over time ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed records of more than 600 vagus nerve stimulation surgeries. Mean surgery duration for those ...

University of Liverpool researchers have begun work on a major £2.7 million National Institute for Health and Care Research (NIHR)-funded trial investigating the long-term effectiveness of vagus nerve ...

London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive ...

The vagus nerve stimulator (VNS) is a pacemaker-like device implanted in the chest that delivers intermittent electrical signals to the brain via an electrode wrapped around the left vagus nerve. The ...

Medical technology company LivaNova has announced the launch of SenTiva Duo, an implantable pulse generator that provides vagus nerve stimulation therapy for patients with drug-resistant epilepsy.

In 1997, the FDA approved implanted vagus nerve stimulation (VNS) devices as an adjunctive therapy for reducing the frequency and severity of epileptic seizures in pharmaco-resistant epilepsy patients ...

A review of randomized controlled trials suggests patients with epilepsy refractory to medical management may benefit from vagal nerve stimulation. A new review suggests that vagal nerve stimulation ...

Burlingame, CA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, exhibiting a ...